Sangamides, a new class of cyclophilin-inhibiting host-targeted antivirals for treatment of HCV infection
Steven J. Moss, Matthew A. Gregory, Barrie Wilkinson(Norwich Research Park), Tony Warneck, Michael Bobardt(Scripps Research Institute), Jinlun Liu(Shanghai Zhangjiang Laboratory), Mohammad Nur‐e‐Alam, Pieter Leyssen(Rega Institute for Medical Research), Nigel Coates(Isomerase Therapeutics (United Kingdom)), Philippe Gallay(Scripps Research Institute), Teresa A. Foster, Johan Neyts(Rega Institute for Medical Research), Chen Yong-sheng(Shanghai Zhangjiang Laboratory), Ming‐Qiang Zhang(China University of Petroleum, East China), Dipen Suthar, Udayan Chatterji(Scripps Research Institute)
Cited by 26
Related Papers
In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral Vector
|Science|1996|4.9k
HIV-1 infection of nondividing cells through the recognition of integrase by the importin/karyopherin pathway
|Proceedings of the National Academy of Sciences|1997|483
HIV nuclear import is governed by the phosphotyrosine-mediated binding of matrix to the core domain of integrase
|Cell|1995|355
Active Site Residues of Cyclophilin A Are Crucial for Its Signaling Activity via CD147
|Journal of Biological Chemistry|2002|338